|
rs11591147
|
PCSK9
R46L
|
Loss-of-function variant that naturally lowers LDL cholesterol by 15-28% and ...
|
Atherogenic Lipoproteins
|
|
Established
|
|
rs12487736
|
SCAP
SCAP Val798Ile
|
Missense variant in the SCAP cholesterol-sensor gene (Val798Ile); the C allel...
|
Atherogenic Lipoproteins
|
|
Moderate
|
|
rs137852912
|
PCSK9
D374Y
|
The most severe gain-of-function PCSK9 mutation, increasing LDLR-binding affi...
|
Atherogenic Lipoproteins
|
|
Established
|
|
rs1125226
|
CYP7A1
CYP7A1 upstream promoter variant
|
Upstream regulatory variant in CYP7A1 that tags haplotypes affecting bile aci...
|
Cholesterol & Lipoproteins
|
|
Emerging
|
|
rs28942111
|
PCSK9
S127R
|
Gain-of-function PCSK9 missense variant (Ser127Arg) causing autosomal dominan...
|
Atherogenic Lipoproteins
|
|
Established
|
|
rs12721627
|
CYP3A4
*16
|
Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst...
|
Pharmacogenomics
|
|
Moderate
|
|
rs505151
|
PCSK9
E670G
|
Common missense variant in PCSK9 exon 12 where the rare G allele raises LDL c...
|
Atherogenic Lipoproteins
|
|
Moderate
|
|
rs12713559
|
APOB
APOB R3558C
|
Rare APOB missense variant reducing LDL-receptor binding affinity by ~40-50%,...
|
Cholesterol & Lipoproteins
|
|
Moderate
|
|
rs137943601
|
LDLR
LDLR E408* (Glu408Ter)
|
Nonsense mutation in the LDLR gene creating a premature stop codon at positio...
|
Cholesterol & Lipoproteins
|
|
Strong
|
|
rs20455
|
KIF6
Trp719Arg
|
Missense variant in kinesin family member 6; the Arg allele was associated wi...
|
Coronary Artery Disease & Atherosclerosis
|
|
Moderate
|
|
rs5925
|
LDLR
LDLR Expression Co-variant
|
Synonymous variant in LDLR exon 13 that modulates mRNA splicing efficiency in...
|
Atherogenic Lipoproteins
|
|
Moderate
|
|
rs6008845
|
PPARA
PPARA intronic C/T
|
Regulatory PPARA variant where TT homozygotes with type 2 diabetes experience...
|
Atherogenic Lipoproteins
|
|
Strong
|
|
rs185392267
|
PCSK9
Arg96Cys
|
Gain-of-function missense variant in PCSK9 that increases intracellular LDL r...
|
Cholesterol & Lipoproteins
|
|
Strong
|
|
rs6511720
|
LDLR
Intron 1
|
Common regulatory variant in the LDL receptor gene affecting LDLR expression,...
|
Atherogenic Lipoproteins
|
|
Strong
|
|
rs2228314
|
SREBF2
SREBF2 G1784C
|
Missense variant in the master cholesterol transcription factor SREBP-2 that ...
|
Cholesterol & Lipoproteins
|
|
Moderate
|
|
rs688
|
LDLR
Asn591Asn (c.1773C>T)
|
Synonymous LDLR variant that disrupts exon 12 splicing, reduces LDL receptor ...
|
Atherogenic Lipoproteins
|
|
Strong
|
|
rs730882094
|
LDLR
Asn316Ser (N316S)
|
Rare likely-pathogenic missense variant in the LDLR EGF-like repeat domain ca...
|
Atherogenic Lipoproteins
|
|
Strong
|
|
rs28942083
|
LDLR
Cys667Tyr
|
Pathogenic LDLR missense variant abolishing LDL receptor surface expression, ...
|
Cholesterol & Lipoproteins
|
|
Established
|
|
rs730882105
|
LDLR
p.Val524Met
|
Rare LDLR missense variant (c.1570G>A, p.Val524Met) associated with familial ...
|
Atherogenic Lipoproteins
|
|
Moderate
|
|
rs28942084
|
LDLR
LDLR Pro685Leu
|
Pathogenic LDLR missense variant in the EGF precursor domain causing familial...
|
Cholesterol & Lipoproteins
|
|
Established
|
|
rs763625913
|
LDLR
Q770* (c.2308C>T)
|
Rare pathogenic nonsense variant in the LDL receptor gene that abolishes rece...
|
Atherogenic Lipoproteins
|
|
Established
|
|
rs28942085
|
LDLR
LDLR Y828C (J.D. mutation)
|
Pathogenic LDLR missense variant (p.Tyr828Cys) that traps LDL receptors outsi...
|
Cholesterol & Lipoproteins
|
|
Established
|
|
rs3846662
|
HMGCR
HMGCR Intron 13 Splice Variant
|
Intronic HMGCR variant that modulates alternative splicing of exon 13, produc...
|
Cholesterol & Lipoproteins
|
|
Moderate
|
|
rs3846663
|
HMGCR
HMGCR Exon 13 Haplotype Tag
|
Intronic HMGCR variant that tags a haplotype influencing exon 13 alternative ...
|
Cholesterol & Lipoproteins
|
|
Strong
|
|
rs2231142
|
ABCG2
Q141K
|
Reduces ABCG2 transporter function affecting rosuvastatin levels and uric aci...
|
Pharmacogenomics
|
|
Established
|
|
rs2242480
|
CYP3A4
*1G
|
Intronic variant in CYP3A4 intron 10 that upregulates a suppressive lncRNA, r...
|
Pharmacogenomics
|
|
Strong
|
|
rs673548
|
APOB
|
Intronic APOB variant associated with modest differences in apolipoprotein B ...
|
Cholesterol & Lipoproteins
|
|
Moderate
|
|
rs8192870
|
CYP7A1
CYP7A1 intron 1 variant
|
Intronic variant in the rate-limiting bile acid synthesis gene; T allele carr...
|
Cholesterol & Lipoproteins
|
|
Moderate
|
|
rs9818870
|
MRAS
|
3' UTR variant near miRNA binding sites in MRAS, associated with ~15% increas...
|
Coronary Artery Disease & Atherosclerosis
|
|
Strong
|
|
rs35599367
|
CYP3A4
*22
|
Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin...
|
Pharmacogenomics
|
|
Established
|
|
rs4148323
|
UGT1A1
*6 Gly71Arg
|
Phase II glucuronidation enzyme that metabolizes bilirubin and many drugs inc...
|
Pharmacogenomics
|
|
Established
|
|
rs4149056
|
SLCO1B1
*5
|
Statin transport - affects muscle side effect risk with statins
|
Pharmacogenomics
|
|
Established
|
|
rs55785340
|
CYP3A4
*2
|
Missense variant reducing CYP3A4-mediated nifedipine clearance, causing eleva...
|
Pharmacogenomics
|
|
Moderate
|